Global Recombinant DNA Technology Market: Overview, Trends, and Forecast 2023-2033

The Global Recombinant DNA Technology Market Size is Anticipated to Exceed USD 1227.3 Billion by 2033, Growing at a CAGR of 5.25% from 2023 to 2033. Recombinant DNA Technology (RDT) refers to the technology that enhances health conditions by creating novel medications and vaccines. RDT is now an essential tool for improving traits in living things and has completely changed the field of biological research. This technology's broad applications in a variety of fields, including industry, agriculture, and medicine, are factors driving its growth. The technology's rising demand has also been influenced by its capacity to produce essential proteins required for preserving nutrition and averting health problems. For example, RDT-produced insulin has proven to be extremely beneficial to diabetic patients all over the world. Also, the development of genetically modified organisms (GMOs) that can function as bio-degraders and producers of clean fuel has been fueled by the rise in urbanization, population growth worldwide, reduction in arable land, and severe food scarcity. This has caused a spike in GMO research, which is anticipated to drive the market even higher.